Literature DB >> 12846487

Avoidance of premature death: a new definition for the proportion cured.

P D Sasieni1, J Adams, J Cuzick.   

Abstract

For many cancers, five-year survival is used as a synonym for cure. For some sites, such as breast, this is inappropriate since there is still considerable excess mortality 5-15 years following diagnosis. We propose using the probability of not dying prematurely as a surrogate for the probability of being cured. This is estimated without the need for information on the cause of death by comparing all-cause-mortality rates in patients with cancer to those in the general population. We also consider the probability of 'cure' in those who have survived a certain number of years since diagnosis. These quantities are estimated for various cancer sites using SEER data. The proportion not dying prematurely varies considerably for common cancers from 12% for lung cancer to 84% for prostate cancer. In women, the percentage 'cured' for colon and breast cancer are very similar at 56% and 58% respectively, but in those who survive 5 years, they are quite different--91% and 78% respectively. The proposed statistic is useful. For diseases in which excess mortality is primarily within five years of diagnosis, it agrees well with 5-year relative survival. Interpretation of differences between countries or over time is complicated and requires consideration of incidence and mortality data.

Entities:  

Mesh:

Year:  2002        PMID: 12846487

Source DB:  PubMed          Journal:  J Cancer Epidemiol Prev        ISSN: 1476-6647


  2 in total

1.  Cumulative morbidity and late mortality in long-term survivors of exocrine pancreas cancer.

Authors:  Nisha L Jacobs; Florencia G Que; Robert C Miller; Santhi Swaroop Vege; Michael B Farnell; Aminah Jatoi
Journal:  J Gastrointest Cancer       Date:  2009

2.  Errors in determination of net survival: cause-specific and relative survival settings.

Authors:  Chloe J Bright; Adam R Brentnall; Kate Wooldrage; Jonathon Myles; Peter Sasieni; Stephen W Duffy
Journal:  Br J Cancer       Date:  2020-02-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.